Last updated on December 2018

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-dependent Chronic Kidney Disease (DD-CKD)


Brief description of study

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with DD-CKD

Detailed Study Description

This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the maintenance treatment of anemia in subjects with DD-CKD

Clinical Study Identifier: NCT02892149

Contact Investigators or Research Sites near you

Start Over

Akebia Therapeutics

Research Site
Tarzana, CA United States
  Connect »

Akebia Therapeutics

Research Site
Encino, CA United States
1.68miles
  Connect »

Akebia Therapeutics

Research Site
Northridge, CA United States
6.24miles
  Connect »

Akebia Therapeutics

Research Site
Panorama City, CA United States
8.21miles
  Connect »

Akebia Therapeutics

Research Site
Granada Hills, CA United States
9.39miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.